UnMASCing diseases of the brain

Researchers uncover proteins underlying devastating brain diseases

UnMASCing diseases of the brain

Microscopic image of brain neuron in a dish. Cell body is on the left and the blue is the dendrites with the points of light in green being the synapse protein machines.

Scientists at the Wellcome Trust Sanger Institute have discovered a set of brain proteins responsible for some of the most common and devastating brain diseases. The proteins underlie epilepsy, depression, schizophrenia, bipolar disease, mental retardation and neurodegenerative diseases including Alzheimer's and Huntington's diseases.

"The reason such a remarkable number of diseases are relevant to this set of proteins is that these proteins are at the heart of how brain cells function."

Professor Seth Grant, Director of the Genes to Cognition Programme at the Wellcome Trust Sanger Institute

Rather than taking traditional methods for studying just one protein at a time, the researchers developed a method that finds whole sets of proteins that bind to each other and form microscopic molecular machines. They were hunting for the 'engine room' of nerve cells, which is known to be inside the connections between nerve cells called synapses.

Synapses join the billions of nerve cells together in the brain and they are the location where learning and memory and many other behaviours are controlled.

"We developed a new method, which led to this discovery, and it should be equally useful in finding the basis of many other diseases in other cells and tissues of the body."

Dr Jyoti Choudhary, leader of the Proteomic Mass Spectrometry team at the Sanger Institute, which collaborated with Professor Grant's team on the study

To find this key set of proteins - called MASCs (a scientific acronym for MAGUK Associated Signaling Complexes and pronounced 'mask') - the researchers adapted a method that had previously been used in yeast cells.

"These approaches have enabled the most specific interrogation of the synapse, in terms of its constituent complexes and have revealed that genes associated with brain diseases such as schizophrenia are highly over-represented within this molecular machine. This is a landmark in terms of characterisation of truly endogenous protein complexes or 'molecular machines', as this is the first time it has been conducted in a higher organism in this way."

Dr Mark Collins, author on the study from the Sanger Institute

The method involved making a 'molecular hook' and attaching it to one protein inside brain cells of mice. They then caught the hook and pulled it out and found it brought along another 100 proteins. The set contained dozens of disease-causing proteins.

"This points to the new concept that the molecular machines are defective in the diseases and that they present new ways to approach therapy."

Dr Jyoti Choudhary, Sanger Institute

Not only were there many disease proteins within the molecular machines but also proteins that control the communication between nerve cells and the mechanisms of learning and memory.

"This research is an important convergence of basic and clinical science. Our findings are exciting because they suggest that the molecular machine itself is at the root of many important brain diseases. This was a blue-skies research project seeking the basic mechanisms of learning and memory and it has led us into some of the inner workings of the brain."

"This is a key step toward new ways to fight mental illness."

Professor Seth Grant, Sanger Institute

Notes to Editors
  • Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins.

    Fernández E, Collins MO, Uren RT, Kopanitsa MV, Komiyama NH et al.

    Molecular systems biology 2009;5;269


This work was supported by a Federation of European Societies postdoctoral fellowship, the Wellcome Trust, Marie Curie Actions: Research Training Network programs and the EPSRC/MRC Doctoral Training Centre in Neuroinformatics and Computational Neuroscience.

Participating Centres
  • Genes to Cognition Programme, The Wellcome Trust Sanger Institute, Cambridge, UK
  • Proteomic Mass Spectrometry, The Wellcome Trust Sanger Institute, Cambridge, UK
  • School of Informatics, Edinburgh University, Edinburgh, UK
Selected Websites
Contact the Press Office

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Emily Mobley, Media Officer

Tel +44 (0)1223 496 851

Wellcome Sanger Institute,
CB10 1SA,

Mobile +44 (0) 7900 607793

Recent News

NUCLEUS project welcomes new consortium member: Wellcome Genome Campus in Cambridge

The ambitious HORIZON 2020 NUCLEUS project has been further strengthened by the joining of the Wellcome Genome Campus in Cambridge, UK as the 25th member of the consortium

First 'non-gene' mutations behind neurodevelopmental disorders discovered

The study is a positive step towards providing an explanation for children with undiagnosed neurodevelopmental disorders

Sanger Institute opens up its life sciences leadership development courses

Five bespoke courses tailored to the needs of leaders at all levels, from new supervisors to established managers, are being offered to the scientific community